Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06305637Phase 1Completed
Phase 1, randomised, double-blind trial of Ketoconazole Cream in tinea versicolor (3 arms). Primary endpoint: Therapeutic Equivalence and Safety of the Investigational Product at Day 28. Started Dec 2023; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06305637.